Cantor Fitzgerald analyst Sarah James initiated coverage of Molina Healthcare (MOH) with an Overweight rating and $354 price target. Molina is trading relatively inline with Centene (CNC) despite having an incrementally better win rate in 2021-2022 and lower risk to upcoming contract renewals in 2023-2024, the analyst tells investors in a research note. The firm believes Molina’s valuation does not account for its improved contract award performance and low incumbency risk in upcoming proposals.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MOH: